Johnson & Johnson and other leading US drug distributors agree to $26bn settlement with states over their role in opioid epidemic | WHAT REALLY HAPPENED

Johnson & Johnson and other leading US drug distributors agree to $26bn settlement with states over their role in opioid epidemic

US pharmaceutical giant Johnson & Johnson and the nation’s three biggest drug distributors have agreed to pay a combined $26 billion to end the legal liability for their alleged roles in spurring the nation’s opioid crisis.

Attorneys general from seven states announced the deal on Wednesday, saying that Johnson & Johnson would pay $5 billion and distributors McKesson, Cardinal Health, and AmerisourceBergen about $21 billion combined. The money will be paid out over time – nine years for Johnson & Johnson and 18 years in the case of the distributors – and will go to states that agree to accept the settlement and forgo pursuing their own lawsuits against the companies.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA